{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:43Z","timestamp":1707525343944},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,25]]},"DOI":"10.7759\/cureus.47654","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T14:41:12Z","timestamp":1698244872000},"source":"Crossref","is-referenced-by-count":0,"title":["Insulin Requirements During Severe COVID-19 Were Relatively Low in Japanese Patients With Type 2 Diabetes: Two Case Reports"],"prefix":"10.7759","author":[{"given":"Junpei","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koudai","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Igusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh AK","year":"2020","unstructured":"Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020, 14:303-10. 10.1016\/j.dsx.2020.04.004","journal-title":"Diabetes Metab Syndr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes","volume":"31","author":"Zhu L","year":"2020","unstructured":"Zhu L, She ZG, Cheng X, et al.. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes. Cell Metab. 2020, 31:1068-1077.e3. 10.1016\/j.cmet.2020.04.021","journal-title":"Cell Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1857","article-title":"Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis","volume":"44","author":"Klonoff DC","year":"2021","unstructured":"Klonoff DC, Messler JC, Umpierrez GE, et al.. Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis. Diabetes Care. 2021, 44:578-85. 10.2337\/dc20-1857","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0780","article-title":"Association of early-phase in-hospital glycemic fluctuation with mortality in adult patients with coronavirus disease 2019","volume":"44","author":"Chen L","year":"2021","unstructured":"Chen L, Sun W, Liu Y, et al.. Association of early-phase in-hospital glycemic fluctuation with mortality in adult patients with coronavirus disease 2019. Diabetes Care. 2021, 44:865-73. 10.2337\/dc20-0780","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim S","year":"2021","unstructured":"Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021, 17:11-30. 10.1038\/s41574-020-00435-4","journal-title":"Nat Rev Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment","volume":"33","author":"Wu CT","year":"2021","unstructured":"Wu CT, Lidsky PV, Xiao Y, et al.. SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment. Cell Metab. 2021, 33:1565-1576.e5. 10.1016\/j.cmet.2021.05.013","journal-title":"Cell Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo W","year":"2020","unstructured":"Guo W, Li M, Dong Y, et al.. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020, 36:e3319. 10.1002\/dmrr.3319","journal-title":"Diabetes Metab Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein SR","year":"2020","unstructured":"Bornstein SR, Rubino F, Khunti K, et al.. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020, 8:546-50. 10.1016\/S2213-8587(20)30152-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14288","article-title":"COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients","volume":"93","author":"Wu L","year":"2020","unstructured":"Wu L, Girgis CM, Cheung NW. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol (Oxf). 2020, 93:390-3. 10.1111\/cen.14288","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0602-9","article-title":"\u03b2 cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians","volume":"15","author":"Yabe D","year":"2015","unstructured":"Yabe D, Seino Y, Fukushima M, Seino S. \u03b2 cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015, 15:602. 10.1007\/s11892-015-0602-9","journal-title":"Curr Diab Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0022","article-title":"Managing hyperglycemia in the COVID-19 inflammatory storm","volume":"69","author":"Gianchandani R","year":"2020","unstructured":"Gianchandani R, Esfandiari NH, Ang L, Iyengar J, Knotts S, Choksi P, Pop-Busui R. Managing hyperglycemia in the COVID-19 inflammatory storm. Diabetes. 2020, 69:2048-53. 10.2337\/dbi20-0022","journal-title":"Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in Covid-19","volume":"383","author":"Rubino F","year":"2020","unstructured":"Rubino F, Amiel SA, Zimmet P, et al.. New-onset diabetes in Covid-19. N Engl J Med. 2020, 383:789-90. 10.1056\/NEJMc2018688","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-020-00632-2","article-title":"Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report","volume":"20","author":"Jornayvaz FR","year":"2020","unstructured":"Jornayvaz FR, Assouline B, Pugin J, Gariani K. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. BMC Endocr Disord. 2020, 20:155. 10.1186\/s12902-020-00632-2","journal-title":"BMC Endocr Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/cd20-0036","article-title":"Insulin resistance in a hospitalized COVID-19 patient: a case review","volume":"39","author":"Seggelke SA","year":"2021","unstructured":"Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin resistance in a hospitalized COVID-19 patient: a case review. Clin Diabetes. 2021, 39:228-32. 10.2337\/cd20-0036","journal-title":"Clin Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s40842-021-00121-y","article-title":"Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases","volume":"7","author":"Affinati AH","year":"2021","unstructured":"Affinati AH, Wallia A, Gianchandani RY. Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases. Clin Diabetes Endocrinol. 2021, 7:8. 10.1186\/s40842-021-00121-y","journal-title":"Clin Diabetes Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-021-00500-x","article-title":"Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report","volume":"12","author":"Satomura A","year":"2021","unstructured":"Satomura A, Oikawa Y, Nakanishi S, et al.. Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report. Diabetol Int. 2021, 12:474-9. 10.1007\/s13340-021-00500-x","journal-title":"Diabetol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.02.012","article-title":"Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes","volume":"53","author":"Fukushima M","year":"2004","unstructured":"Fukushima M, Usami M, Ikeda M, et al.. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004, 53:831-5. 10.1016\/j.metabol.2004.02.012","journal-title":"Metabolism"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1235","article-title":"Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis","volume":"36","author":"Kodama K","year":"2013","unstructured":"Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013, 36:1789-96. 10.2337\/dc12-1235","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard H","year":"2011","unstructured":"Ellingsgaard H, Hauselmann I, Schuler B, et al.. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011, 17:1481-9. 10.1038\/nm.2513","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0723","article-title":"Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?","volume":"43","author":"Sardu C","year":"2020","unstructured":"Sardu C, D'Onofrio N, Balestrieri ML, et al.. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control?. Diabetes Care. 2020, 43:1408-15. 10.2337\/dc20-0723","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","volume":"14","author":"Bode B","year":"2020","unstructured":"Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, Klonoff DC. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J Diabetes Sci Technol. 2020, 14:813-21. 10.1177\/1932296820924469","journal-title":"J Diabetes Sci Technol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1506","article-title":"Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19","volume":"43","author":"Seiglie J","year":"2020","unstructured":"Seiglie J, Platt J, Cromer SJ, et al.. Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes Care. 2020, 43:2938-44. 10.2337\/dc20-1506","journal-title":"Diabetes Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072555","article-title":"Glycemic control in critically ill COVID-19 patients: systematic review and meta-analysis","volume":"12","author":"Chander S","year":"2023","unstructured":"Chander S, Deepak V, Kumari R, Leys L, Wang HY, Mehta P, Sadarat F. Glycemic control in critically ill COVID-19 patients: systematic review and meta-analysis. J Clin Med. 2023, 12:10.3390\/jcm12072555","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001476","article-title":"Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study","volume":"8","author":"Wu J","year":"2020","unstructured":"Wu J, Huang J, Zhu G, et al.. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res Care. 2020, 8:10.1136\/bmjdrc-2020-001476","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194052-insulin-requirements-during-severe-covid-19-were-relatively-low-in-japanese-patients-with-type-2-diabetes-two-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:45Z","timestamp":1707509265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194052-insulin-requirements-during-severe-covid-19-were-relatively-low-in-japanese-patients-with-type-2-diabetes-two-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.47654","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,25]]}}}